Takeda Pharmaceutical Co. Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Takeda Pharmaceutical Co. Ltd.
In December 2022, Nimbus Inc. completed one of the largest single-asset deals in the history of biotech, selling their TYK2 inhibitor program NDI-034858 for an up-front payment of $4bn and up to $2bn in additional milestone payments. What was it like to close a deal of that magnitude? What’s next for Nimbus? The company‘s CEO, Jeb Keiper, reflected on these questions in a recent interview with In Vivo.
Mid-sized M&A, collaborations, creative financing, and biotech consolidation will feature in 2023. IPOs and follow-ons play bit-parts.
The upcoming year could see a rebound approvals if the bigger-than-usual queue of novel agents with 2023 user fee goal dates pans out.
Leading Japanese firm reports solid growth in its fiscal nine months as it hints more may be to come after recent major deals to expand the mid- to late-stage pipeline and highlights progress for some key internal assets.
- Other Names / Subsidiaries
- Adaptate Biotherapeutics Ltd
- Altos Therapeutics LLC
- AR Scientific, Inc. (URL)
- ARIAD Pharmaceuticals, Inc.
- Bradley Pharmaceuticals, Inc
- Cellerix SA
- Cerevance, Envoy Therapeutics, Inc.
- Chordia Therapeutics
- ChromaJean, Inc.
- GammaDelta Therapeutics
- IDM Pharma
- Intellikine, Inc.
- Inviragen, Inc.
- LigoCyte Pharmaceuticals, Inc.
- Maverick Therapeutics, Inc.
- Millennium Pharmaceuticals, Inc.
- Mutual Pharmaceutical Company, Inc. (URL)
- Nihon Pharmaceutical Co., Ltd
- Nycomed Pharma AS
- Pharmaceutical Holdings Corporation (URL)
- PvP Biologics, Inc.
- sanaplasma AG
- Syrrx, Inc.
- TAP Pharmaceutical Products, Inc.
- Teva Takeda Pharma Ltd.
- Shire Pharmaceuticals Group PLC (SHPG)
- Teva Takeda Yakuhin Ltd.
- TiGenix NV
- URL Pharma, Inc. Advanced BioHealing, Inc. (renamed Shire Regenerative Medicine)
- AesRX LLC
- Baxalta Incorporated
- BIKAM Pharmaceuticals Inc.
- Chatham Therapeutics
- Dyax Corp.
- FerroKin BioSciences, Inc.
- Fibrotech Therapeutics
- Foresight Biotherapeutics Inc.
- Gambro AB
- Jerini AG
- Lotus Tissue Repair
- Lumena Pharmaceuticals
- Meritage Pharma, Inc.
- Movetis NV
- New Pervasis Therapeutics, Inc.
- NPS Pharmaceuticals, Inc.
- Premacure AB
- Prism Pharmaceuticals, Inc.
- River Pharmaceuticals
- Roberts Pharmaceutical Corporation
- SARcode Corporation
- SuppreMol GmbH
- Synovis Life Technologies, Inc.
- Transkaryotic Therapies, Inc.
- ViroPharma Inc.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.